HARVARD BIOSCIENCE INC 8-K

What Happened
Harvard Bioscience, Inc. (HBIO) filed a Form 8-K on March 17, 2026, under Item 7.01 (Regulation FD Disclosure) to disclose and attach its current corporate slide presentation. The presentation, dated March 2026, is included as Exhibit 99.1 and is incorporated by reference in the filing.

Key Details

• Filed date: March 17, 2026 (Form 8-K).
• Disclosure type: Item 7.01 — Regulation FD Disclosure (corporate slide presentation).
• Exhibit: 99.1 — Corporate slide presentation of Harvard Bioscience, dated March 2026.
• Interactive data: Cover Page Interactive Data File included as Exhibit 104 (Inline XBRL).

Why It Matters
This is a routine regulatory filing that makes Harvard Bioscience’s current investor/analyst slide deck publicly available. Investors should review the attached Exhibit 99.1 to see the company’s latest messaging, strategy summaries, and any operational or market updates presented to the investment community. Because the filing is a disclosure of presentation materials (not an earnings release or management change), it does not itself report financial results, but it can provide useful context for company outlook and investor presentations.